An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies
Yafei LiuDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanWai Tuck SohLaboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanJun-ichi KishikawaLaboratory for CryoEM Structural Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, JapanMika HiroseLaboratory for CryoEM Structural Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, JapanEmi E. NakayamaDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanSongling LiDepartment of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanMiwa SasaiDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanTatsuya SuzukiInstitute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanAsa TadaLaboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanAkemi ArakawaLaboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanSumiko MatsuokaDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanKanako AkamatsuDepartment Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanM. MatsudaDepartment Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory for Supramolecular Crystallography, Institute for Protein Research, Osaka University, Osaka 565-0871, JapanChikako OnoLaboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanShiho ToriiLaboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanKazuki KishidaLaboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanHui JinDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, JapanWataru NakaiDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanNoriko AraseDepartment of Dermatology, Graduate school of Medicine, Osaka University, Osaka 565-0871, JapanAtsushi NakagawaDepartment of Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo 650-0047, JapanMaki MatsumotoDrug Discovery Research Center, HuLA immune, Inc., Osaka 565-0871, JapanYukoh NakazakiDrug Discovery Research Center, HuLA immune, Inc., Osaka 565-0871, JapanYasuhiro ShindoDrug Discovery Research Center, HuLA immune, Inc., Osaka 565-0871, JapanMasako KohyamaDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, JapanKeisuke TomiiDepartment of Respiratory Medicine, Kobe City Medical Center General Hospital, Hyogo 650-0047, JapanKoichiro OhmuraDepartment of Rheumatology, Kobe City Medical Center General Hospital, Hyogo 650-0047, JapanShiro OhshimaDepartment of Clinical Research, Osaka Minami Medical Center, Kawachinagano, Osaka 586-8521, JapanToru OkamotoInstitute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, JapanMasahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, JapanHironori NakagamiDepartment of Health Development and Medicine, Graduate school of Medicine, Osaka University, Osaka 565-0871, JapanYoshiharu MatsuuraLaboratory of Virus Control, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, JapanTakayuki KatoLaboratory for CryoEM Structural Biology, Institute for Protein Research, Osaka University, Osaka 565-0871, JapanMasato OkadaDepartment Oncogene Research, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, JapanDaron M. StandleyDepartment of Genome Informatics, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, JapanTatsuo ShiodaDepartment of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, JapanHisashi AraseDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan; Laboratory of Immunochemistry, World Premier International Immunology Frontier Research Centre, Osaka University, Osaka 565-0871, Japan; Center for Infectious Disease Education and Research, Osaka University, Osaka 565-0871, Japan. Electronic address: [email protected]
2021en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0